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While it is well-established that distal hypoxia response elements (HREs) regulate hypoxia-inducible 
factor (HIF) target genes such as erythropoietin (Epo), an interplay between multiple distal and 
proximal (promoter) HREs has not been described so far. Hepatic Epo expression is regulated by a 
HRE located downstream of the EPO gene, but this 3' HRE is dispensable for renal EPO gene 
expression. We previously identified a 5' HRE and could show that both HREs direct exogenous 
reporter gene expression. Here, we show that whereas in hepatic cells the 3' but not the 5' HRE is 
required, in neuronal cells both the 5' and 3' HREs contribute to endogenous Epo induction. Moreover, 
two novel putative HREs were identified in the EPO promoter. In hepatoma cells HIF interacted mainly 
with the distal 3' HRE, but in neuronal cells HIF most strongly bound the promoter, to a lesser extent 
the 3' HRE, and not at all the 5' HRE. Interestingly, mutation of either of the two distal HREs abrogated 
HIF binding to the 3' and promoter HREs. These results suggest that a canonical functional HRE can 
recruit multiple, not necessarily HIF, transcription factors to mediate HIF binding to different distant 
HREs in an organ-specific manner. 
 
Article Summary 
Hypoxia-inducible EPO gene expression is regulated by a 3' HRE in the liver but this element is not 
required for EPO induction in other organs and the DNA elements required for EPO regulation 
remained elusive. 
Using CRISPR-Cas9 mediated gene editing we could demonstrate that a novel 5' HRE - despite not 
binding HIF - functionally cooperates with the 3' HRE and newly discovered promoter HREs to direct 





Erythropoietin (Epo) is indispensable for the maintenance of a normal blood oxygen concentration and 
Epo synthesis is induced under anemic and hypoxic conditions.
1, 2
 In the adult, Epo production by the 
kidney and liver account for approx. 90% and 10%, respectively, of total circulating Epo, but ectopic 
Epo expression was also found in the brain, uterus and testis, among others, where it is thought to 
have pleiotropic, organ-restricted and tissue protective functions.
3-6
 Renal Epo is synthesized by 
peritubular pericytes with fibroblastic and neuronal features, located in the juxtamedullary cortex.
7-9
 
These cells respond to a decrease in tissue oxygen partial pressure by hypoxia-inducible factor (HIF)-
2α stabilization and HIF-2-dependent transcriptional induction of EPO gene expression.
10
 HIFs bind to 
a hypoxia response element (HRE) containing the essential core consensus sequence 5'-RCGTG-3' 
which, however, is not sufficient to confer hypoxia-inducible gene expression.
11
 Distinct regulatory 
DNA elements enhance EPO promoter activity in liver and kidney. Transgenic mouse models showed 
that in the liver 0.7 kb of the immediate 3'-flanking region is required, whereas in the kidney the 
essential regulatory element resides between -14 and -6 kb in the distal 5'-region.
12-15
 The 3' HRE is 
well established and has been shown to be necessary and sufficient for liver-specific EPO gene 
expression after embryonic day 14.5.
16, 17
 However, the DNA element responsible for kidney-specific 
EPO gene expression is far less well characterized and nothing is known about the endogenous HREs 
in Epo-producing cells of other tissues.  
 We recently discovered a strongly conserved distal 5' HRE and suggested that it might 
contribute to oxygen-regulated EPO expression.
18
 This 5' HRE resides within a DNaseI hypersensitive 
site -9.2 kb upstream of the EPO transcriptional start site, contains both the 5'-ACGTG-3' core HIF 
DNA binding site as well as the ancillary 5'-CACA-3' element,
11
 and confers hypoxia-inducible 
exogenous reporter gene expression in Epo expressing and non-expressing cell lines.
18
 However, the 
organ-specific relevance of the endogenous 5' and 3' HREs as well as their functional interaction with 
the EPO promoter remained unknown. Considering the neuronal features that we and others reported 
for the renal Epo-producing cells,
8, 9
 we hence analyzed the relative contribution of the 5' and 3' HREs 
in Kelly cells, a human neuroblastoma cell line that has previously been shown to regulate the EPO 
gene in an oxygen and HIF dependent manner.
19
 Endogenous HRE function was investigated by gene 
editing and HIF-DNA interaction studies. Intriguingly, novel promoter HREs were identified and 
profound differences in the functional cooperation between the 5', 3' and promoter HREs in Kelly cells 









Human Hep3B and HepG2 hepatocellular carcinoma (American Type Culture Collection, LGC 
Standards, Wesel, Germany) and Kelly neuroblastoma (kindly provided by J. Fandrey, Essen, 
Germany) cell lines were cultured in high glucose Dulbecco's modified Eagle's medium (DMEM) and 
RPMI-1640 medium, respectively (Sigma Aldrich, Saint Louis, MO, USA), supplemented with 10% 
heat-inactivated fetal bovine serum (Thermo Fisher Scientific, Waltham, MA USA), 50 IU/ml penicillin 
and 50 µg/ml streptomycin (Sigma Aldrich). Cells were exposed to hypoxic conditions using a 





Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) 
gene editing was performed as reported
22
 and is described in detail in the Supplementary Methods.  
 
RNA and protein analyses 
RNA was extracted and quantified by reverse-transcription (RT) real-time quantitative (q) PCR as 
described previously
21, 23
 In brief, RT was performed with 2 µg total RNA and AffinityScript reverse 
transcriptase (Agilent), and the cDNA quantified using SYBR Green qPCR reagent kit (Kapa 
Biosystems, London, UK) in a MX3000P light cycler (Agilent). Transcripts levels were calculated 
through comparison with calibrated standard curves and normalized to human ribosomal protein L28 
mRNA. Primers used for RT-qPCR are listed in Supplementary Table 1. Epo protein was detected by 
ELISA according to the manufacturer's protocol (R&D Systems, Minneapolis, MN, USA). 
Immunoblotting was performed as described previously
21
 using the following primary antibodies: 
mouse monoclonal anti-HIF-1α (#610959; BD Transduction Laboratories, San Jose, CA, USA), rabbit 
monoclonal anti-HIF-2α (#PAB12124; Abnova, Taipei, Taiwan), mouse monoclonal anti-HIF-β (D28F3; 
Cell Signaling Technology, Danvers, MA, USA), mouse monoclonal anti-β-actin (A5441; Sigma 
Aldrich). Secondary antibodies were HRP-conjugated goat polyclonal anti-rabbit or anti-mouse IgG 
(#31460 and #31430, respectively; Thermo Fisher Scientific). 
 
Luciferase reporter gene assays 
Reporter gene constructs have been described previously.
18
 Canonical 5'-RCGTG-3' HREs were 
replaced by 5'-RAAAG-3' using site-directed mutagenesis. Following transfection with lipofectamine, 
cells were incubated under normoxic or hypoxic (0.2% O2) conditions for 24 hours. Reporter gene 
assays were performed as described before,
21
 using a luciferase assay kit (Promega, Madison, 









HIF chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) experiments were performed as described previously,
21, 25, 26
 
using the following rabbit polyclonal antibodies: anti-HIF-1α (PM14), anti-HIF-2α (PM9), anti-HIF-β 
(NB100-110; Novus Biologicals, Littleton, CO, USA), normal rabbit serum (X0902; Dako, Glostrup, 
Denmark). Co-precipitated DNA was quantified by real-time qPCR using the primers listed in 
Supplementary Table 1.  
 
Statistical analysis 
All data are shown as mean + SEM. Unpaired two-tailed Student's t-tests were applied. Differences 






Mutation of the EPO 5' and 3' HREs by gene editing 
CRISPR-Cas9 technology was used for the specific destruction of the endogenous EPO HREs to 
dissect the relative contribution of the -9.2 kb 5' HRE and the +3.0 kb 3' HRE to hypoxia-inducible 
EPO gene expression in neuronal and hepatic cell lines (Figure 1A). As shown in Figure 1B, sgRNAs 
were designed to target the HIF-binding core sequence 5'-ACGTG-3'.
11
 The restriction enzyme TaiI 
was used to assess the presence of the 5'-ACGT-3' sequence.
27
 Successful HRE destruction confers 
TaiI resistance to the PCR products as exemplified for Kelly cells in Figures 1C and D. Monoclonal cell 
lines were obtained by limiting dilution cloning of initial partially gene edited polyclonal cell pools. The 
HRE regions were again amplified by PCR, re-tested for complete TaiI resistance, and cloned into 
plasmid vectors. Multiple independent plasmids were sequenced to ensure biallelic HRE inactivation. 
Alternatively, amplicons were directly deep sequenced. Clone verification and sequence information is 
provided in Supplementary Figure 1. Note that in some cases (Kelly-3'B2, Hep3B-5'H11) more than 
two mutant alleles were detected which may be due to either polyclonal cell lines, polyploidy, gene 
amplification or genetic drift. Other clones maintained wild-type HRE sequences (Kelly-5'C4, Kelly-
3'C4, Hep3B-5'A5, HepG2-5'H8, HepG2-3'D6; confirmed by sequencing of PCR products) and were 
included as additional controls in subsequent experiments.  
 
The 5' HRE contributes to hypoxic EPO induction in neuronal but not hepatic cells 
The neuroblastoma cell line Kelly has been reported to induce endogenous Epo mRNA levels, at 24 
hours, by over 71-fold under hypoxic conditions (3% O2) and over 238-fold under anoxic conditions.
19
 
Kelly cells hence recapitulate the well-known hypoxia-inducible EPO gene expression in the brain.
4
 As 
shown in Figure 2, Epo mRNA and secreted protein were induced by 1603-fold and 22-fold, 
respectively, following exposure of wild-type Kelly cells to hypoxia (0.2% O2) for 24 hours. However, 
due to the very low basal Epo transcript levels, the fold induction factor is subject to variation and must 
be interpreted with caution. Indeed, the wild-type HRE subclones Kelly-5'C4 and Kelly-3'C4 showed 
reduced Epo mRNA induction, even though the hypoxic Epo mRNA levels were not significantly 
different from the maternal Kelly cells (Figure 2A). These results were confirmed on the protein level 
where the normoxic levels also varied greatly but the hypoxic levels were indistinguishable from the 
maternal cell line (Figure 2B). Therefore, only hypoxic Epo levels were considered for subsequent 
analyses. 
 Interestingly, all mutant 5' and 3' HRE Kelly clones showed significantly reduced hypoxic Epo 
expression, on the mRNA (Figure 2A) as well as on the protein (Figure 2B) level. This is in striking 
contrast to mutant Hep3B (Figure 2C, D) and HepG2 (Figure 2E) clones, where only 3' but not 5' HRE 
mutations strongly reduced hypoxic Epo mRNA and protein levels. Note that while Kelly and Hep3B 
cells were exposed to hypoxia for 24 hours, HepG2 cells showed maximal Epo mRNA induction 
already after 8 hours, with approx. 10-fold lower mRNA levels, which was not sufficient for detectable 
Epo protein accumulation in the supernatant. To ensure that no general off-target effects caused these 
results, the mRNA levels of the HIF-1 and HIF-2 target genes CAIX and LOXL2 (Kelly) or PAI1 
(Hep3B and HepG2), respectively,
28
 were measured in the same samples. As shown in 
7 
 
Supplementary Figure 2, EPO HRE mutations did not significantly reduce the expression of these 
genes under hypoxic conditions. Moreover, also hypoxic HIF-1α and HIF-2α protein stabilization was 
not altered by the EPO HRE mutations (Supplementary Figure 3). These results suggest that both the 
5' and 3' HREs contribute to hypoxia-inducible EPO gene expression in neuronal cells whereas in 
hepatic cells only the 3' HRE is required.  
 
The 5' and 3' EPO HREs cooperatively enhance hypoxic reporter gene expression in neuronal 
cells 
We had previously shown that the EPO 5' HRE confers hypoxia-inducible expression to a 
heterologous SV40 promoter-driven reporter gene in both Hep3B and Kelly cells.
18
 These results 
stand in apparent contrast to the 5' HRE mutation data presented above and imply differences 
between exogenous bacterial reporter gene plasmids and endogenous chromatin regulation. In fact, 
similar reporter gene results have been obtained even in non-Epo-expressing HeLa and HK-2 cells
18
 
as well as in Hek293 and CHO cells (data not shown). We hence expanded these experiments by 
transiently transfecting Kelly cells with minimal (138 bp) EPO promoter-driven reporter genes, 
enhanced by various DNA fragments containing the 5' and/or 3' HREs. In contrast to our previous 
results obtained with Hep3B cells,
18
 EPO promoter-driven luciferase activity in Kelly cells was 
significantly further elevated when the 100 bp fragment containing the 5' HRE was combined with a 
126 bp fragment containing the 3' HRE (Figure 3A). While a longer 3 kb DNA fragment containing the 
5' HRE reduced both hypoxic and normoxic reporter gene expression driven by the EPO promoter/3' 
HRE, it actually led to even higher hypoxic induction factors. These data imply a cooperation between 
the EPO 5' and 3' HREs specifically in neuronal cells, and suggest that additional distal and proximal 
5' flanking elements contribute to tissue-specific and conditional EPO regulation. 
 
A novel EPO promoter HRE contributes to hypoxic reporter gene expression in neuronal cells 
Interestingly, a slight but significant hypoxic induction of the minimal EPO promoter could be seen in 
Kelly cells (Figure 3A) which we previously did not observe in Hep3B cells.
18
 Inspection of the 147 bp 
fragment containing the 138 bp EPO promoter revealed a tandem dimeric repeat with two previously 
not reported putative HREs (Figure 3B). These putative HREs are highly conserved and locate close 
to WT1 and GATA binding sites (Supplementary Figure 4). In combination with the 5' and 3' HRE 
enhancers, luciferase expression driven by this promoter fragment was induced 152-fold by hypoxia in 
this experimental series. Mutation of either promoter HRE (pHRE) 1 or pHRE2 significantly reduced 
hypoxic luciferase expression levels, whereas the effect on the hypoxic induction factors was less 
conclusive (Figure 3C). Double pHRE1 and pHRE2 mutation did not further decrease reporter gene 
expression, suggesting that this tandem dimeric sequence in the EPO promoter acts as a single HRE. 
Similar results were obtained with Hep3B cells (Figure 3D), though absolute as well as hypoxically 






HIF interacts with the EPO promoter and 3' HRE but not 5' HRE in neuronal cells 
To directly analyze the interaction between HIF and the various HREs of the endogenous EPO locus, 
chromatin immunoprecipitation followed by real-time PCR quantification (ChIP-qPCR) experiments 
were performed. Because of the contribution of the promoter to the hypoxic activation of reporter gene 
expression observed above, we also included the proximal 5' region in these ChIP-qPCR experiments 
(Figure 4A). Unexpectedly, Kelly cells did not show any significant binding of the HIF subunits HIF-1α, 
HIF-2α or HIF-β to the 5' HRE, whereas a significant hypoxic increase in HIF-2α/HIF-β binding to the 
3' HRE could be detected (Figure 4B). Surprisingly, however, the strongest HIF interaction in hypoxic 
Kelly cells was observed with the EPO promoter region, again with a preference for HIF-2α/HIF-β. In 
contrast, in hypoxic Hep3B cells the strongest HIF-2α/HIF-β interaction was found at the 3' HRE and 
only a weak interaction with the promoter region could be observed (Figure 4C). Similar findings have 
previously been reported for hypoxic HepG2 cells using ChIP-seq,
29
 whereas non-Epo-producing cell 
lines did not show any HIF binding to the EPO locus (Supplementary Figure 5). To control for ChIP 
efficiency, the presence of DNA fragments containing the HRE of the HIF-1/2 target genes NDRG1 
and PAI1
21, 25
 was quantified by qPCR in the same samples. HIF binding to the established NDRG1 
and PAI1 promoter HREs was comparable to the Epo HREs, and anti-HIF-β antibodies precipitated 
roughly additive amounts of chromatin seen with the HIF-1α and HIF-2α antibodies (Figures 4B, C). 
 
Functional distal 3' and 5' HREs are required for remote control of HIF binding to the EPO 
promoter 
Because ChIP resolution is insufficient to detect the precise protein-DNA interaction site, we next 
wanted to confirm that HIF actually bound the core sequence of the investigated HREs. Therefore, 
Hep3B 3' and 5' mutant HRE subclones were exposed to hypoxia and used for ChIP with anti-HIF-β 
antibodies to precipitate both HIF-1 and HIF-2. As expected, HIF bound the wild-type 3' HRE but did 
not interact anymore with the mutant 3' HRE (Figure 4D). Of note, the 3' HRE mutation apparently also 
decreased the weak HIF interaction with the EPO promoter region. Consistent with its non-functionality 
in Hep3B cells, mutation of the 5' HRE did not influence HIF binding to any of the tested HREs (Figure 
4D). HIF-β binding to the PAI1 control HRE (Figure 4D) as well as HIF-β protein levels (Figure 4E) 
were not altered in these Hep3B subclones, confirming that HIF-β expression is not generally affected 
by the 3' and 5' HRE mutations and that HIF-β ChIP reliably detects HIF-DNA interactions. 
 To further investigate the unexpected inhibitory effect of the distal 3' HRE mutation on the HIF 
interaction with the proximal EPO promoter region in Hep3B cells, these experiments were repeated 
with Kelly 3' and 5' mutant HRE subclones. Intriguingly, the 3' HRE mutation (clone B2) not only 
completely abrogated the interaction between HIF and the 3' HRE, but also strongly decreased the 
interaction with the promoter region (Figure 5A). Moreover, the 5' HRE mutation (clone C3) similarly 
impaired HIF interaction with the 3' HRE and the promoter region (Figure 5A), while comparable HIF 
binding to the NDRG1 control HRE (Figure 5B) and HIF-β protein levels (Figure 5C) could be detected 




Large but not small deletions of the 5' HRE abrogate Epo induction in 3'/5' HRE double-mutant 
neuronal cells 
Because there was residual HIF binding to the EPO promoter in the single 3' and 5' HRE mutant Kelly 
subclones, we wondered whether 3'/5' HRE double mutations would lead to a further decrease of the 
HIF interaction with the EPO promoter. The introduction of a secondary mutation was rather inefficient 
and worked only in the B2 3' HRE mutant Kelly subclone. Deep sequencing of the PCR products 
derived from the mutant 5' HRE revealed 3 subclones with large (31 bp and 18 bp; varying ratios) and 
3 subclones with small (1, 2 or 3 bp; biallelic) deletions (Supplementary Figure 6A). Despite some 
reduction in CAIX mRNA and HIF-1α protein in the subclones containing the larger deletions, the 
double-mutant subclones did not show major general differences in mRNA levels of the HIF target 
genes CAIX and LOXL2, or in hypoxic HIF-1α and HIF-2α protein levels (Supplementary Figures 6B-
E).  
 In hypoxic Kelly cells, only the larger but not the smaller 5' HRE deletions further decreased HIF 
binding to the EPO promoter in the 3'/5' HRE double-mutant subclones (Figure 5A). The small core 5' 
HRE mutations partly reversed the inhibitory effect of the 3' HRE mutation on HIF promoter interaction. 
HIF-β binding to the NDRG1 control HRE (Figure 5B) as well as HIF-β protein levels (Figure 5C) 
remained at similar levels, confirming that HIF-β expression is not generally affected in these Kelly 
subclones, and that HIF-β ChIP reliably detects HIF-DNA interactions. Consistent with the ChIP data, 
the additional larger or smaller 5' HRE deletions further decreased or partly reversed, respectively, 
Epo mRNA (Figure 5D) and protein (Figure 5E) levels in hypoxic 3' HRE mutant Kelly cells.  
 
The core HIF-binding sites of all EPO HREs are required for hypoxic reporter gene expression 
To further dissect the relevance of the various EPO HREs, the conserved core HIF-binding sites were 
mutated (5'-CGTG-3' to 5'-AAAG-3') in EPO promoter/enhancer-driven reporter gene constructs. 
Mutation of either the 5' or the 3' HRE significantly reduced hypoxic reporter gene expression in Kelly 
cells, with the 5' HRE showing a stronger effect than the 3' HRE. Simultaneous mutation of both sites 
completely abrogated hypoxic reporter gene expression (Figure 6A). Despite the very weak activity of 
the minimal EPO promoter (Figure 3A), even the double mutation of the two EPO promoter HREs 
significantly reduced hypoxic reporter gene expression in these constructs (Figure 6B). Additional 5' or 
3' HRE single or double mutations further reduced or abrogated, respectively, hypoxic reporter gene 
expression (Figure 6B). 
 In contrast to the endogenous EPO 5' and/or 3' HRE deletions by gene editing (see above), 
both HREs contribute to hypoxic EPO promoter induction in exogenous reporter genes transfected into 
Hep3B cells (Figure 6C), like we have previously reported for these cells as well as for non-Epo-
producing cells.
18
 Both, absolute and hypoxically induced reporter gene levels were much lower than 
in Kelly cells. Again, double mutation of the EPO promoter HREs significantly reduced hypoxic 
reporter gene expression, which could only be completely abolished when the 5' and 3' HREs were 





The data presented reveal a complex and organ-specific interplay between various HREs at the EPO 
locus. The previously described mechanisms of EPO regulation in hepatic cells were mostly confirmed 
by our experiments, including a strong functional dependence on the endogenous 3' HRE with a 
robust HIF interaction, and a complete lack of requirement for the endogenous 5' HRE despite a 
strong hypoxic enhancer function in exogenous reporter gene experiments. In neuronal cells, the 
endogenous 5' HRE seems to be as important as the 3' HRE for hypoxic induction of EPO gene 
expression and the 5' and 3' HREs cooperate in hypoxic enhancement of exogenous reporter gene 
expression, but the 5' HRE does not directly interact with HIF. In contrast to hepatic cells, where the 
EPO promoter is only slightly bound by HIF and does not confer hypoxic reporter gene induction 
18
, in 
neuronal cells it is the EPO promoter that most strongly interacts with HIF, consistent with a weak 
hypoxic induction of reporter genes. EPO minimal promoter fragments spanning at least -91 bp 
upstream of the transcriptional start site have previously been shown to be hypoxia responsive in 
reporter gene experiments also in Hep3B cells.
30, 31
 
 It is currently unclear why we repeatedly found significant hypoxic promoter induction only in 
Kelly but not Hep3B cells. Inspection of the minimal EPO promoter region revealed two potential HREs 
characterized by the presence of evolutionary conserved 5'-GCGTG-3' HIF binding motifs. Mutation of 
either of these two HREs in Kelly cells reduced both basal and hypoxia-inducible promoter activity 
enhanced by the 5' and 3' HREs. Tissue-specific transcriptional co-activators and/or co-repressors 
may be involved in the difference in hypoxic promoter activity and HIF binding between hepatic and 
neuronal cells. Indeed, a cooperative interaction with additional transcription factors binding in close 
proximity to HIF is typical for HREs and has also been found in other HIF target genes.
21
 While the 
ancillary 5'-CACA-3' element
11
 is missing, its supportive function may be replaced by the neighbouring 
DNA binding sites for GATA factors and the Wilms tumor gene (WT1) product, which are well-known 
to regulate the EPO promoter.
32-35
 It has recently been shown that WT1 is itself hypoxia-inducible and 
restricted to neuroblastoma and kidney-derived cell lines,
9, 36
 which might contribute to both hypoxia-
inducible as well as tissue-specific EPO promoter activity. Alternatively, it is possible that binding of 
HIF to the promoter and/or transcriptional activation may be blocked by binding of a currently unknown 
tissue-specific factor in Hep3B cells. Of note, we have previously shown that ATF/CREB family 
members are able to directly interact with the HRE core motif,
37
 and it may be that such an interaction 
also occurs at the promoter HREs. 
 How could it be explained that a conserved HRE consensus core sequence, including the 
ancillary element, is functionally relevant for hypoxic induction of gene expression but not directly 
bound by HIF, as it appears to be the case for the EPO 5' HRE? We have previously shown for PAG1, 
another HIF-2 target gene, that a single distal -82 kb 5' HRE resides in an isolated DNA region, bound 
by many additional transcription factors, and forms multiple chromatin loops both locally and over a 
long distance with the promoter region.
21
 While in this case HIF-2α did interact with the HRE, neither 
hypoxia nor the presence of HIF was needed for the long-range chromatin interaction with the 
promoter region. Only the presence of the core 5'-ACGTG-3' HIF binding DNA sequence was required 
to maintain this interaction, suggesting that pre-formed chromatin loops enable oxygen-regulated 
11 
 
conditional gene regulation. This model has subsequently been confirmed for many other HIF target 
genes by genome-wide approaches.
38, 39
 Therefore, the EPO 5' HRE might well be functionally 
required for hypoxia-inducible gene expression by maintaining a constitutive chromatin architecture 
that supports promoter activity in a cell type-specific manner. The finding that only additional large but 
not small 5' HRE deletions fully abrogated endogenous Epo induction and HIF:promoter interaction in 
3' HRE mutant Kelly cells suggests that, like in the case of the PAG1 gene, additional transcription 
factors bind close to the consensus HRE sequence and are involved in chromatin looping and trans-
activation of the EPO promoter. We have currently no explanation why a small 5' HRE deletion alone 
inhibited HIF-promoter interaction, but in combination with a 3' HRE mutation partially rescued the 
inhibitory effect of the 3' HRE mutation. Nonetheless, it is without precedent that the extended 5' HRE 
strongly cis-enhanced HIF binding to the promoter and 3' HREs.  
 The differences between Epo-producing hepatic and neuronal cells raise the question of how 
EPO is regulated in renal Epo-producing (REP) cells, the main source of circulating Epo. The overlap 
of neuronal markers with genetically tagged mouse REP cells
8, 9
 suggests that Kelly cells may 
represent a better model than hepatoma cells to recapitulate human oxygen-regulated EPO gene 
expression in the kidney, at least concerning the enigmatic 5' regulatory regions. Indeed, deletion of 
the endogenous 3' HRE in the mouse suppressed only hepatic but not renal Epo expression, 
suggesting the presence of one or more additonal HREs in REP cells.
17
 Consistently, deletion of a -
17.4 to -3.6 kb Epo 5' region in transgenic mouse models abrogated Epo gene expression specifically 
in REP cells whereas it was dispensable for Epo expression in the brain.
31
 Mutation of the mouse -8.3 
kb 5' HRE (corresponds to the human -9.2 kb 5' HRE) within this Epo 5' region, did not abrogate 
transgenic Epo gene expression in the kidney (brain was not analyzed) and a minimal 0.3 kb fragment 
containing this 5' HRE was not sufficient to drive transgenic GFP expression in the mouse kidney.
31
 
Our results on the cooperation between 5', 3' and promoter HREs in neuronal and hepatic cell lines 
may help to explain these findings in transgenic mice: while the deletion of the 3' HRE in the liver is 
sufficient to abrogate hypoxic Epo expression, only the combined deletion of the extended 5' and the 
minimal 3' (and maybe the promoter) HREs may affect Epo expression in the kidney. 
 Altogether, these results demonstrate that several HREs are involved in oxygen-regulated EPO 
gene expression. While in the liver the 3' HRE is both necessary and sufficient, in the kidney the 3' 
HRE is dispensable and a 5' HRE acts in concert with additional long-range enhancer elements and 
probably local chromatin structure. Although transgenic mouse models are still lacking, our results 
suggest that in the brain, both of these distal HREs functionally cooperate with HIF binding to promoter 
HREs. Our results further illustrate that not all HREs act in a canonical way by directly binding HIF, 
and that HRE-promoter cooperations in oxygen-regulated gene expression need to be analyzed in a 
cell type-specific context and cannot be generalized based on the results obtained with a single cell 
line. Similar results have recently been reported for the MALAT1 locus, expressing a lncRNA which is 
strongly hypoxia-inducible,
40
 where HIF-dependent and independent long-range interactions contribute 
to hypoxia-inducibility in a cell-type specific manner.
41
. Finally, our findings are also relevant for 
disease-associated polymorphisms that either create or delete potential HREs
26, 42, 43
 and may hence 
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Figure 1. EPO 5' and 3' HRE gene editing. (A) Scheme depicting the human EPO locus (HRE, 
hypoxia response element; HSS, hypersensitivity site; TSS, transcriptional start site; KIE, kidney 
inducible element; NRE, negative regulatory element; LIE, liver inducible element; NRLE, negative 
regulatory liver element). (B) Single-guided (sg) RNA sequences designed to target the EPO 5' and 3' 
HREs by CRISPR-Cas9 (bold, consensus HIF binding site; arrows, PCR primers used to amplify the 
HRE regions; fwd, forward; rev, reverse; wt, wild-type; mt, mutant). Mutation of the consensus HRE 
confers resistance to TaiI restriction digestion as shown by agarose gel analysis of digested or 
undigested PCR products using as template genomic DNA isolated from Kelly neuroblastoma cells 
following 5' (C) or 3' (D) HRE gene editing (M, marker; PL, polyclonal pool of cells; B4 and C3, 5' HRE 
mutant clones; T1 and F3, 3' HRE mutant clones; ctr, non-template control). 
 
Figure 2. Hypoxia-inducible EPO gene expression in 5' or 3' HRE mutant neuroblastoma and 
hepatoma cells. EPO expression under normoxic or hypoxic conditions (0.2% O2; 24 h for Kelly and 
Hep3B, 8 h for HepG2) was measured in Kelly (A, B), Hep3B (C, D) and HepG2 (E) cells by RT-qPCR 
on the mRNA level (A, C, E) and by supernatant ELISA on the protein level (B, D). Epo mRNA levels 
were normalized to ribosomal protein L28 mRNA levels. Numbers above the columns indicate hypoxic 
induction factors. Data are shown as mean + SEM of 3 independent experiments. Student's t-tests 
were used to statistically evaluate the difference between hypoxic gene edited cells and hypoxic wild-
type (WT) cells (*, p<0.05; **, p<0.01; ***, p<0.001; n.d., not detectable; Pool, polyclonal pool of cells; 
+/+, subclones containing two wild-type alleles; -/-, subclones with biallelic HRE mutation). 
 
Figure 3. EPO promoter-driven and HRE-enhanced luciferase reporter gene expression. Kelly (A, C) 
and Hep3B (D) cells were transiently transfected with the indicated reporter gene constructs and 
exposed for 24 hours to normoxic or hypoxic (0.2% O2) conditions. Luciferase activities were 
normalized to the protein content and shown as mean values + SEM of 6 (A, C) or 3 (D) independent 
experiments. Numbers on the right of the bars indicate hypoxic induction factors. Student's t-tests 
were used to statistically assess hypoxic EPO promoter activities (EpoProm, wild-type; mtpHRE, 
mutant) and the effects of combining the 5' with the 3' HRE (*, p<0.05; **, p<0.01; ***, p<0.001). (B) 
Sequence of the 147 bp human EPO promoter fragment (starting 138 bp upstream of the transcription 
start site; TSS), indicating a conserved tandem dimeric repeat (underlined), each containing a putative 
promoter HRE (pHRE1 and pHRE2). 
 
Figure 4. HIF binding to the EPO locus in 5' or 3' HRE mutant neuroblastoma and hepatoma cells. (A) 
Scheme depicting the regions of the EPO locus analyzed for HIF interaction by chromatin 
immunoprecipitation (ChIP), including the 5' and 3' HREs, the minimal promoter and a negative (neg.) 
control region devoid of any HIF binding. Kelly (B) and Hep3B (C) cells were exposed for 24 hours to 
normoxic or hypoxic (0.2% O2) conditions, followed by ChIP using antibodies derived against HIF-1α, 
HIF-2α or HIF-β, or a negative control serum. The promoter HRE of the established HIF target genes 
NDRG1 and PAI1 served as control for ChIP efficiency. The amount of co-precipitated DNA was 
17 
 
determined by qPCR and displayed relative to input. (D) These experiments were repeated with 
hypoxic wild-type (WT), 5' or 3' HRE mutant Hep3B cells. Mean values + SEM of 3 (Kelly) or 4 (Hep3B) 
independent experiments are shown. Student's t-tests were performed to statistically evaluate the 
difference between the hypoxic ChIP samples and hypoxic serum controls (*, p<0.05; **, p<0.01, ***, 
p<0.001). (E) Immunoblot confirmation of similar HIF-β protein levels in the hypoxic Hep3B subclones 
used above. β-Actin was used as loading and blotting control. 
 
Figure 5. HIF binding to the EPO locus and Epo regulation in 3'/5' HRE double-mutant neuroblastoma 
cells. (A, B) ChIP of hypoxic WT or mutant (as indicated) Kelly cells using antibodies derived against 
HIF-β or negative control serum. The amount of co-precipitated DNA was determined by qPCR 
covering the indicated regions of the EPO locus (A) or the HRE of the NDRG1 control locus (B) and 
displayed relative to input. Data are shown as mean + SEM of 4 independent experiments. Student's t-
tests were performed to statistically evaluate the difference to hypoxic WT (*, p<0.05) or 3' B2 (
#
, 




, p<0.01). (C) Immunoblot confirmation of similar HIF-β protein 
levels in the hypoxic Kelly subclones used above. β-Actin was used as loading and blotting control. (D, 
E) Epo production in wild-type (WT), single 3' B2 or double 3' B2 5' HRE mutant Kelly cells exposed 
for 24 hours to normoxia or hypoxia (0.2% O2) was measured by RT-qPCR on the mRNA level (D) or 
by ELISA on the protein level (E). Data are shown as mean + SEM of 3-6 (D) or 5-10 (E) independent 
experiments. Student's t-tests were used to statistically evaluate the difference to hypoxic WT (**, 




, p<0.001; ns, not significant; n.d., not detectable).  
 
Figure 6. EPO promoter/enhancer-driven luciferase reporter gene expression following single and 
combined HRE mutations. Kelly (A, B) and Hep3B (C, D) cells were transiently transfected with the 
indicated reporter gene constructs and exposed for 24 hours to normoxic or hypoxic (0.2% O2) 
conditions. Luciferase activities were normalized to the protein content and shown as mean values + 
SEM of 4 independent experiments. Numbers on the right of the bars indicate hypoxic induction 
factors. Student's t-tests were used to statistically assess hypoxic EPO promoter activities (*, p<0.05; 










Supplementary Table 1. Oligonucleotide sequences. 
 
sgRNA construction oligonucleotides (only sense strands shown) 
5'hre-sgrna 5'-ccctgcacgtatgtgctccgggc-3' 
3'hre-sgrna 5'-ccctacgtgctgtctcacacagc-3' 
EPO HRE PCR amplification primers 
5'hre-fwd 5'-tggctgcggacatttctatc-3' 
5'hre-rev 5'-gatgcaggagcctggttcac-3' 
5'hre-rev (deep seq.) 5'-ttcagtggcaatgtggaggt-3' 
3'hre-fwd 5'-gcacctaccatcagggacag-3' 
3'hre-rev 5'-gccctgggcagggttg-3' 
















ChIP qPCR quantification primers Used for: 
EPO-5'HRE-fwd 5'-gatggagctgtgtctccctg-3' Figure 4 
EPO-5'HRE-rev 5'-agtggcaatgtggaggtctg-3' Figure 4 
EPO-5'HRE-fwd  5'-ggctgcggacatttctatca-3' Figure 5 





EPO-3'HRE-fwd 5'-cagcagtgcagcaggtccaggtcc-3' Figure 4 
EPO-3'HRE-rev 5'-cgagaggtcagacaggctgtgtgag-3' Figure 4 
EPO-3'HRE-fwd 5'-cttcaacctcattgacaagaactg-3' Figure 5 











Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) 
gene editing was performed as described.1 The EPO locus was screened for single guide RNA 
(sgRNA) binding sites using CRISPR Design Tool.2 Oligonucleotides containing the sgRNA 
sequences (Supplementary Table 1) were synthesized (Microsynth, Balgach, Switzerland), annealed 
and ligated into plasmid MLM3636 (#43860; Addgene, Middlesex, UK). Cells were co-transfected with 
expression vectors for sgRNA, Cas-9 (ToolGen, Seoul, South Korea) and puromycin resistance 
(linearized pBabe vector; #1764; Addgene) using polyethylenimine (Polysciences, Warrington, PA, 
USA) for Hep3B and HepG2, and lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) for Kelly cells. 
Puromycin (1.5 µg/ml, Hep3B; 1 µg/ml, HepG2; 0.2 µg/ml, Kelly) was added two days after 
transfection for up to two weeks. Gene edited cells were cloned by limiting dilution and genotyped by 
PCR using High Fidelity Phusion Polymerase (Thermo Fisher Scientific) and the primers listed in 
Supplementary Table 1. Amplicons were analyzed either by TaiI digestion (Thermo Fisher Scientific) 
followed by 2% agarose gel electrophoresis to check for HRE destruction,3 or by sub-cloning into 
pBluescript vector (Agilent, Santa Clara, CA, USA) and plasmid DNA sequencing (Microsynth), or by 
direct DNA deep sequencing (Functional Genomics Center Zurich).  
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5' HRE alleles                                                    clone#
WT catacgtgcagggagacacagctccatccagc
C4 catacgtgcagggagacacagctccatccagc  2  
C3 catac-tgcagggagacacagctccatccagc  8
B4 catac-tgcagggagacacagctccatccagc  4
B4 c--------------acacagctccatccagc  3
A
3' HRE alleles                                                                                                                              clone#
WT agcaggtccaggtccgggaaacgaggggtggagggggctgggccctacgtgctgtctcacacagcc
C4 agcaggtccaggtccgggaaacgaggggtggagggggctgggccctacgtgctgtctcacacagcc   2
T1 ag----------------------------------------------------tctcacacagcc   9
B2 agcaggtccaggtccgggaaacgaggggtggagggggctgggccctacg---------acacagcc   1
B2 agcaggtccaggtccgggaaacgaggggtggagggggctgggccctac-tgctgtctcacacagcc   2
B2 ag----------------------------------------------------tctcacacagcc   3
B2 agcaggtccaggtccgggaaacgaggggtggagggg--------------gctgtctcacacagcc   1
B2 agcaggtccaggtccgggaaacgaggggtggagggggctgggccctacgt--tgtctcacacagcc   1
F2 ag----------------------------------------------------tctcacacagcc   1
F2 agcaggtccaggtccgggaaacgaggggtggagggggctgggccctacg---------acacagcc   3




5' HRE alleles                                                                 clone#(Seq%)
WT  agcacatacgtgcagggagacacagctccatccagc
A5  agcacatacgtgcagggagacacagctccatccagc   2
B5  agc-------tgcagggagacacagctccatccagc   6
B5  agcacatac-tgcagggagacacagctccatccagc   4
H11 agcacatac-tgcagaaggagacacagctccatccagc 6   (40%)
H11 agcacatac-tgcagggagacacagctccatccagc   9
H11 agcacatat-tgcagggagacacagctccatccagc   2   (35%)
H11 agcacatacggagcagggagacacagctccatccagc  0   (20%)
B10 agc-------tgcagggagacacagctccatccagc   7
B10 agcacatac-tgcagggagacacagctccatccagc   7
D
3' HRE alleles                                              clone#
WT ggccctacgtgctgtctcacacagcctgt
D4 ggccctacggtgctgtctcacacagcctgt  2
D4 ggccctacggggctgtctcacacagcctgt  2
E6 ggc--------------tcacacagcctgt  2
E6 ggaactgca--gctgtctcacacagcctgt  2
F
HepG2
3' HRE alleles                                                                                           clone#
WT acgaggggtggagggggctgggccctacgtgctgtctcacacagcctgt
D6 acgaggggtggagggggctgggccctacgtgctgtctcacacagcctgt    2
F2 acgag--------------------------------------gcctgt   10
E2 acgaggggtggagggggctgggccctacggtgctgtctcacacagcctgt  11
B6 acgaggggtggagggg--------------gctgtctcacacagcctgt    8
J
5' HRE alleles                                                             clone#
WT agcacatacgtgcagggagacacagctccatccagc
H8 agcacatacgtgcagggagacacagctccatccagc   2
A2 agc-------tcca------------tcc-tccagc   6
B5 435 bp deletion                       10
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3' HRE gene editing
Supplementary Figure 1. Generation and analysis of EPO 5' and 3' mutant HRE clonal cell lines. 
Following mutation of the EPO 5' and 3' HREs by CRISPR-Cas9, Kelly (A, B), Hep3B (D, F) and HepG2 
(H, J) cells were cloned by limiting dilution, the HRE regions amplified by PCR, and the amplicons either 
subcloned or directly deep sequenced (bold, consensus 5'-ACGTG-3' and 5'-CACA-3' HRE core and 
ancillary elements, respectively; WT, wild-type; dashes, nucleotide deletions; highlighted, nucleotide 
exchanges). The number of independent plasmids harboring the same sequence (clone#) and the 
percentage of deep sequence reads (Seq%) are indicated on the right. Like outlined for Kelly cells in 
Figure 1, mutation of the consensus HIF binding site confers resistance to TaiI restriction digestion as 
shown by agarose gel analysis of digested or undigested PCR products using as template genomic DNA 
isolated from Hep3B (C, E) and HepG2 (G, I) cells (M, marker; wt; wild-type; Pool, polyclonal pool of 
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Supplementary Figure 2. Hypoxic induction of HIF target genes in EPO 5' and 3' mutant HRE clonal 
cell lines. Kelly (A, B), Hep3B (C, D) and HepG2 (E, F) samples shown in Figure 2 were analyzed for 
the mRNA levels of the HIF target genes carbonic anhydrase (CA) IX (A, C, E), lysyl oxidase like (LOXL) 
2 (B) and plasminogen activator inhibitor (PAI) 1 (D, F) by RT-qPCR. Transcript levels were normalized 
to ribosomal protein L28 mRNA and shown as mean + SEM of 3 independent experiments. Numbers 
above the columns indicate hypoxic induction factors. Student's t-tests were used to statistically evaluate 
the difference to hypoxic wild-type (WT) cells (*, p<0.05; Pool, polyclonal pool of cells; +/+, subclones 
containing two wild-type alleles; -/-, subclones with biallelic HRE mutation). Note that neither the hypoxic 
























































WT H11 B10 B5
-/- -/- -/-



















































210.2 210.2 210.2 210.2



























Supplementary Figure 3. Hypoxic stabilization of HIF-1a and HIF-2a in EPO 5' and 3' mutant HRE 
clonal cell lines. Kelly (A, B), Hep3B (C, D) and HepG2 (E, F) wild-type (WT) cells and 5' HRE (A, C, E) 
or 3' HRE (B, D, F) mutant subclones were exposed to hypoxia (0.2% O2) for 24 hours followed by 
immunoblotting for HIF-1a and HIF-2a. b-Actin was used as loading and blotting control. Note that HIFa 
protein stabilization was not affected by EPO HRE mutations. 
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CC GGGTGGCCC ACCCCTGGCGACCCCTCACGCAC CAGCCTC CCCCACCCCCACCCGCGCACGCACACATGC GATAACA CCCCGACCCCCGGCC GAGC GCAG GTCCC GGGCCACCC GGCGG AC T AT T A G T T C T
CCCCGGGTGGCCCC ACC GGCGACCCCTCACGCACACAGCCTC CCCCCACCCCCACCCGCGCACGCACACATGCAGATAACAGCCCCGACCCCCGGCC AGCC CAG GTCCC GG CCACCC GGCC TTG A GC A T C A T
CCCC GGTGGCCCC ACCCCTGGCGACCCCTCACGCACACAGCCTC CCCCCACCCCCACCCGCGCACGCACACATGC GATAACA CCCCGACCCCCGGCC GAGCC CAG GTCCC GG CCA CC GGCA C A T T G A T C A G TCCCC GGTGGCCCC ACCCCTGGCGACCCCTCA GCACACAGCCTC CCCCCACCCCCACCCGCGCACGC CA C T A G ------------------------------------------------------------CCCC GGTGGCCCC ACCCCTGGCGACCCCTCACGCACACAGCCTC CCCCCACCCCCACCCGCGCACGCACACATGC GATAACA CCCCGACCCCCG CC GAGCC CAG GTCCC GG CCA CC GGCA C A T T A G A T C A G T
CCCC GGTGGCCCC ACC CTGGCGACCCCTCACGCACACAGC TC CCCCCACCCCCACCCGCGCACGCACACATGC GATAACA CCCCGACCCCCGGCC GAGCC CAG GTCCC GG CCACCC GGCA C T T A T T G A T G A TCCCC GGTGGCCCC ACC CTGGCGACCCCTCACGCACACAGC TC CCCCCACCCCCACCCGCGCACGCACACATGC GATAACA CCCCGACCCCCGGCC GAGCC CAG GTCCC GG CCACCCCGGCA C T T A T T G A T C A
CCCCG GTGGCCCC ACCCC GGCGACCCCTCACGCACACAGCCTC CCCCCACCCCCA C GCGCACGCACACA GC GATAACAGCCCCGACCCCCG CC GAGCCGCAG GTCCC GGGCCACCC G CC C C A - G G T - G T C T ACCCCG GTGGCCCC ACC CTGGCGACCCCTCACGCACACAGCCTC CCCCCACCCCCA C CGCGCACGCACACA GC GATAACAGCCCCGACCCCCGA C T A - G A T -
CCCCG GTGGCCCC ACC C GGCGACCCCTCA GCACACAGCCTC CCCCCACCCCCA C CGCGCACGCACACA GC GATAACAGCCCCGACCCCCGA C T C G A - G A T -
CCCCGG TG CCCC ACCCC GGCGACCCCTCACGCACAC CTCT C CC ACC G GCC A C G TTT TAA TTG TT G T ------------------------------------------------------------------
CCCC GGCCC ACC C GCGACCCCTCACGCACACAGCCT CCCCCA CCCC C C CGCACGCACACA GC GATAACAGCCCCGACCCCCGGCC GCCGCAG TCCC GGGCCACCCCGGC-TCC AC T CC -C A C A A - T GCC -- CCCCC GGCCCC CC C GCGACCCCTCACGCACACAG C CCCCCC CCCC C C CGCGCACGCACA GC GATAACAGCCCCGACCCCCGGCC GCCGCAGAGTCCC GGGCCACCCCGGC-TCC CC T CC - C-C A C A A - T GCC C
CCCC GGCCCC CC C GCGACCCCTCACGCACACAGCC CCCCCA CCCC C C CGCACGCACACA GC GATAACAGCCCCGACCCCCGGCC GCCGCAGAGTCCC GGGCCACCCCGGC-TCC CC T CC C-C A C A A - T GCC C
CCCC GG CCC ACC C GCGACCCCTCACGCACACAGCCT CCCCCA CCCC C C CGCACGCACACA GC GATAACAGCCCCGACCCCCGGCC GCCGCAGAGTCCC GGGCCACCCC GC-TCC T C T CC -C A C A C - T GCC C
CCCC TGGCCCC AC C GGCGAC CCTCACGC CAG CT CC C C GCACGCA A A C GATAA A CCCCG C C GCCA AGCC G CC GGGCC-TC C TT C T GAG T -------- T TC AGAA G G GC T A C C- GA C C CTC --GA C --------CCCC TGGCCCC ACC C GCGACCCCTCACGC CACAGCCT CCCCCAC C CGCACGCACACA GC GATAACAGCCC CCCCGGCC AGCC CAG TCCC GGGCCACCC GGC-TC C T CC G -------- A A G T GAC- GC A -- CCCCC TGGCCC TACC CTGGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCC G C AGCCGCAG TCCC GGGCCACCC GG-TC T T -C A A T A A G- -- C G
CCCC TGGCCC TACC CTGGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCG CC AGCCGCAG TCCC GGGCC CCC GGC-TC T T -C A A T A G- -- C G -
CCCC TGGCCCC ACC C GGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCGGCC AGCC CAG TCCC GGGCCAC CCG C--C C T G -- A A T GC T -- G T T
CC C TGGCCCC AC CC GGCGACC CTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCGGCC AGCCGCAG TCCC GGGCCAC CCG CT --A C T G A -- A A T GC -- C G A
CC C TGGCCCC ACC C GGCGACC CTCACGCACACAGCCT CCC CACCCCCAC C CGCACGCACACATGGAAGATAACAGCCCCGACCCCCGGC AGCCGCAG TCCC GGGCCAC CCGGCT --A C T G A -C G A A GC -- C G
   C GGCCC GACCCCTCACGCACACAG CT CCCCC CCCCC C GCGCACGCACACA C GATAAC CC CCCCCGGC AGAGCCGCAG TCCC GG C CCCC-CCA GC--------- T -C C C GG GC T -- GGCG G -- C C AG
CCCC TGGCCCC ACC C GGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGCAGATAACAGCCCCGACCCCCGGCC AGCC CAG TCCC GGGCCAC CCG C--C C T G -- A A GC T -- C T T
CC C TGGCCCC AC CC GGCGACC CTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACA GCAGATAACAGCCCCGACCCCCGGCC AGCCGCAG TCCC GGGCCAC CCGGCT --A C T G A -C A A G GC -- C G
CCCC TGGCCCC ACC C GCGACCCCTCACGCACACAGC T CCCCCACCCCCAC C CGCACGCACACA GC GATAACAGCCCCGACCCCCGGCCAGAGCCGCAG TCC GG C ACCCC GC-TC C T CT T -C A A G T -- GG C A CCCC G GTGGCCCC ACC CTGGCGACCCCTCACGCACACA CCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCGGC GAGCCGCAGAGT CC G GCCACCC GGCT A C T C TA A A T TG T C A T
T CC A C - G A ---C T C A A T A A GC A GCT AA G GCCCG TGG CCC ACC C GGCGACCCC CACGCACACAGC CCCCCAC CCC C C CGCACGCACACATGC GATAACA CCCCGACCCCC GCC AGC GC GTCCC GG C CCCCGGC
T A CC C T G A ---C A A T A A GC A ---T AA G GC CG TGGCCCC ACC C GGCGACCCC CACGCACACAGC CCCCCACCCCCAC C CGCACGCACACATGC GATAACA CCCCGACCCCC GCC AGC G GTCCC GG C CCCCGGC
CCCCG TGGCCCC ACC C GGCGACCCCTCACGCACACA CCT CCCCCACCCCCAC C CGCACGCACACA GC GATAACAGCCCCGACCCCCGGCC GAGCCGCA AGTCCC GGGCCA CC GGTT C T C C GG A A C T C C G G G G
CCCC GGTGGCCCC ACC C GGCGACCCCTCACGCACACA CCTC CCCCCACCCCCACCCGCGCACGCACACATGC GATAACAGCCCCGACCCCCGGC GAGCCGC AGTCCC G GCCACCC GGCT C T C C A T GG -- C A T
CCCCG GTGGCCCC ACC CTGGCGACCCCTCACGCACAC CCCCCACCCCCAC C CGCACGCACACATGC GATAA AGCCCCGACCCCC GC GAGCCGCA AGTCCC G GCCACCC GGCC C T ------A A A T T A TG C C A T
CCCCG GTGGCCCC ACC CTGGCGACCCCTCACGCACACA CCTC CCCCC CCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCGGC GAGCCGCAGAGT CC G GCCACCC GGCC C T C A C A A T TG T C A T
CCCCG GTGGCCCC ACC C GCGACCCCTCACGC CACA CCTC CCCCCACCCCCAC CGCGCACGCACACATGCAGATAACA CCCCGACCCCCGGC GAGCCGCAGAGTCCC G GCC C C G CC C T CC G C A A A TG C A C G T A
CCCC TGGCCC TACC CTGGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGACCCCCGGCC AGCCGCAG TCCC GGGCCACCC GGC-TC T T -C A A T G- -- C -
CCCCGGGTGGCCCCTACCCCTGGCGACCCCTCACGCACACAGCCTCTCCCCCACCCCCACCCGCGCACGCACACATGCAGATAACAGCCCCGACCCCCGGCCAGAGCCGCAGAGTCCCTGGGCCACCCCGGC
pHRE1
--------- T T T -C A A T -----------------------------------G CCCT CC CTGGCGACCCCTCACGCACACAGCCT CCCCCACCCCCAC C CGCACGCACACATGC GATAACAGCCCCGAC GGC





























































Supplementary Figure 4. Putative EPO promoter HREs. Location of two conserved potential promoter 
HREs (pHRE1 and pHRE2; green) close to the GATA (blue) and WT1 (yellow) sites in the EPO proximal 
5' region. Shown is a UCSC Genome Browser output (version hg19), including 161 transcription factor 
ChIP-sequencing (ChIP-seq) tracks derived from the ENCODE database (version 3), clusters of DNaseI 
hypersensitivity sites (HSS) from 125 cell types, and the transcriptional start site (TSS), with a closer 
view of the region in 50 vertebrates extracted using the 100-MULTIZ whole-genome multiple sequence 























































Supplementary Figure 5. UCSC Genome Browser output (hg19) of the EPO (A) and PAG1 (B) 
genomic regions. HIF-1a, HIF-2a and HIF-b ChIP-seq data of hypoxic non-Epo-producing renal 
proximal tubule HKC-8 and VHL-deficient clear cell renal cell carcinoma RCC4 as well as of Epo-
producing hepatoma HepG2 cell lines are indicated. The PAG1 locus confirms HRE binding by all three 
factors in all cell lines analyzed. In addition, the ENCODE integrated regulation tracks containing ChIP-
seq data of 161 transcription factors and DNaseI hypersensitivity (HS) clusters are displayed, aligned to 
the conservation scores of 100 different vertebrate species. Arrows indicate the 5' and 3' HREs of the 
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5' HRE alleles in 3' HRE mutant B2 background                                           deletion (Seq%)
WT  ctcaggcccggagcacatacgtgcagggagacacagctccatccagcttc
B22 ctcaggccc-------------------------------atccagcttc  31 bp   (76%)
B22 ctcaggcccggagcaca------------------gctccatccagcttc  18 bp   (22%)
C19 ctcaggccc-------------------------------atccagcttc  31 bp   (72%)
C19 ctcaggcccggagcaca------------------gctccatccagcttc  18 bp   (24%)
D1  ctcaggccc-------------------------------atccagcttc  31 bp   (85%)
C24 ctcaggcccggagcacatac-tgcagggagacacagctccatccagcttc   1 bp   (94%)
I9  ctcaggcccggagcacatac--gcagggagacacagctccatccagcttc   2 bp   (99%)






































































Supplementary Figure 6. Generation and analysis of EPO 5'/3' HRE double-mutant cell lines. (A) 
Following 5' HRE mutation of the Kelly 3' HRE mutant B2 subclone by CRISPR-Cas9 mediated gene 
editing, the resulting 5'/3' HRE double-mutant subclones were analyzed by PCR amplification and direct 
deep sequencing (bold, consensus 5'-ACGTG-3' and 5'-CACA-3' HRE core and ancillary elements, 
respectively; WT, wild-type; dashes, nucleotide deletions). The size of the HRE deletion and the 
percentage of deep sequence reads (Seq%) are indicated on the right. (B, C) Kelly samples shown in 
Figure 5D were analyzed for the mRNA levels of the HIF target genes carbonic anhydrase (CA) IX (B) 
and lysyl oxidase like (LOXL) 2 (C) by RT-qPCR. Transcript levels were normalized to ribosomal protein 
L28 mRNA and shown as mean + SEM of 3 independent experiments. Numbers above the columns 
indicate hypoxic induction factors. Student's t-tests were used to statistically evaluate the difference to 
hypoxic WT (*, p<0.05; **, p<0.01,) or 3' B2 cells (#, p<0.05; ##, p<0.01; ###, p<0.001). (D, E) Kelly 
samples shown in Figure 5C were analyzed for the protein levels of HIF-1a and HIF-2a by 
immunoblotting. b-Actin was used as loading and blotting control.  
